London, United Kingdom, September 16th, 2026, Chainwire

DataMEDS AI (NASDAQ:MEDS) just made a sharp turn toward one of healthcare’s biggest opportunities: artificial intelligence-powered cancer diagnostics and precision oncology, with the completion of its acquisition of Helomics Corporation from Axe Compute (NASDAQ:AGPU), acquiring a CLIA/CAP-certified clinical laboratory, the Predictive Oncology CRO central-lab business and $1.5 million in cash. The transaction has a total purchase value of $1.5 million, consisting of DataMEDS common shares and an acquisition note.

Fort Lauderdale, Florida, September 15th, 2026, FinanceWire

Wah Fu Education (NASDAQ:WAFU) is betting that its next growth story won’t be written in the classroom, it will be powered by AI agents.